Bariatric Surgery Associated With Remission of Prediabetes and Type 2 Diabetes
Investigators assessed outcomes 5 years after bariatric surgery among patients with obesity and type 2 diabetes.
Investigators assessed outcomes 5 years after bariatric surgery among patients with obesity and type 2 diabetes.
Investigators assessed the associations between bariatric surgery and de novo alcohol-related outcomes.
A team of researchers investigated the effect of bariatric surgery on testosterone levels in adolescents with severe obesity.
Obesity and its related complications are a risk factor for adverse outcomes in people who contract COVID-19 infection. Investigators studied whether losing weight improved outcomes in people who lost weight after weight reduction surgery.
Investigators compared outcomes between adolescents with obesity that did and did not proceed to metabolic and bariatric surgery after referral.
Investigators tested the safety and efficacy of the osculating circles gastroplasty technique for use during bariatric surgeries.
Sleeve gastrectomy and RYGB are highly effective for reducing hepatic steatosis in patients with severe obesity and type 2 diabetes, with almost complete clearance of liver fat one year after surgery.
Among models and validation studies reviewed, the ABCD and DiaRem models most accurately predicted type 2 diabetes remission after bariatric surgery.
Investigators compared 4-year health care expenditures between Roux-en-Y gastric bypass and sleeve gastrectomy.
Among patients with nonalcoholic steatohepatitis (NASH) and obesity, bariatric surgery is associated with a significantly lower risk for adverse liver and cardiovascular outcomes.